| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |